NextCell Pharma AB
NXTCL | ST
Overview
Corporate Details
- ISIN(s):
- SE0009723125 (+1 more)
- LEI:
- 549300PBFGB5JYKXGA45
- Country:
- Sweden
- Address:
- Hälsovägen 7, 141 57 Huddinge
- Website:
- https://nextcellpharma.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
NextCell Pharma AB focuses on stem cell therapies for diabetes and immune system disorders. Their research targets innovative treatment approaches.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Kamada Ltd. | Israel | KMDA | |
|
Kancera | Sweden | KAN | |
|
Kuros Biosciences Ltd. | Switzerland | KURN | |
|
Lidds AB | Sweden | LIDDS | |
|
Lifecare ASA | Norway | LIFE | |
|
Lineage Cell Therapeutics Inc. | Israel | LCTX | |
|
Lipidor AB | Sweden | LIPI | |
|
Lipigon Pharmaceuticals AB | Sweden | LPGO | |
|
Lipum AB | Sweden | LIPUM | |
|
Lonza Group AG | Switzerland | LONN |